Squarepoint Ops »

Monopar Therapeutics shares owned by Squarepoint Ops

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2025-12-31 $687k 11k 65.30

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Apple (AAPL)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Broadcom (AVGO)
Ishares Tr Msci Emg Mkt Etf Put Option (EEM)
Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Semiconductr Etf (SMH)

View all positions for Squarepoint Ops

Top funds holding Monopar Therapeutics

Henderson Group
Adage Capital Partners GP
RA Capital Management
Saturn V Capital Management
Vanguard Group
BlackRock
ADAR1 Capital Management
Wellington Management Company
Siren
Deerfield Management Company
TCG Crossover Management
Polar Capital Holdings
Geode Capital Management
Deep Track Capital
Vivo Capital

View all funds holding Monopar Therapeutics